Alnylam Pharmaceuticals
ALNY
#650
Rank
HK$309.12 B
Marketcap
HK$2,315
Share price
-0.66%
Change (1 day)
1.82%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company